BeyondSpring Inc. is projected to rise to $1.52 by 2027, a +6% move from its current price of $1.44. BYSI is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.38 | $1.44 | $1.50 | -0.04% |
| Jul 13 | $1.36 | $1.44 | $1.52 | -0.07% |
| Jul 14 | $1.34 | $1.44 | $1.54 | -0.11% |
| Jul 15 | $1.33 | $1.44 | $1.56 | -0.15% |
| Jul 16 | $1.31 | $1.44 | $1.57 | -0.18% |
| Jul 17 | $1.30 | $1.44 | $1.58 | -0.22% |
| Jul 18 | $1.29 | $1.44 | $1.60 | -0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.29 | $1.44 | $1.60 | -0.26% |
| Week 2 | $1.23 | $1.43 | $1.66 | -0.51% |
| Week 3 | $1.19 | $1.43 | $1.72 | -0.77% |
| Week 4 | $1.15 | $1.43 | $1.76 | -1.02% |
| Week 5 | $1.12 | $1.42 | $1.80 | -1.28% |
| Week 6 | $1.09 | $1.42 | $1.84 | -1.53% |
| Week 7 | $1.07 | $1.41 | $1.87 | -1.79% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
BeyondSpring Inc. is a clinical stage biopharmaceutical company focused on developing and selling clinical-stage biopharmaceutical therapies centered on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.
The lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC) and for the prevention of chemotherapy-induced neutropenia (CIN). In addition, Plinabulin is studied in combinations such as Plinabulin+docetaxel versus docetaxel alone for NSCLC and epidermal growth factor receptor wild type, and with various immuno-oncology agents and chemotherapy. BeyondSpring was founded in 2010 and is headquartered in Florham Park, New Jersey.
BeyondSpring Inc. (BYSI) is a healthcare stock that trades with a current price of $1.49 and a market capitalization of $61.27M, ranking 4484 by market cap. The stock’s current position sits within a smaller-cap segment of the market.
The long-range price outlook from the provided forecasts shows a path of gradual appreciation, with the average price rising from $1.49 in 2026 to $2.32 in 2030 and $8.23 in 2050, and sentiment shifting to bullish from 2030 onward. The projected returns grow markedly over time, with the forecasted ROI (roiPct) climbing to 55.8% by 2030 and to 452.3% by 2050.
A major floor 19.9% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 29.9% above — a clean break opens room to run.
A major ceiling 39.8% above — clearing it would confirm fresh momentum.
Key BYSI support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BYSI market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.61 | Sell | $1.58 | Sell |
| MA 10 | $1.70 | Sell | $1.64 | Sell |
| MA 20 | $1.66 | Sell | $1.65 | Sell |
| MA 50 | $1.59 | Sell | $1.63 | Sell |
| MA 100 | $1.59 | Sell | $1.63 | Sell |
| MA 200 | $1.70 | Sell | $1.68 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.07 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -177.72 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | -10.56 | Sell |
| Bollinger %B (20,2) | -0.01 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 30.51 | Neutral |
| Momentum (10) | -0.16 | Sell |
| Aroon Osc (25) | -20.00 | Sell |
| Hull MA (9) | 1.49 | Sell |
| ADX (14) | 13.47 | Neutral |
| ATR (14) | 0.06 | Info |
In the near term, the 30-day technical picture remains bearish. The RSI (14) sits at 40, and the price trades near the $1.49 support level. The 50-day simple moving average is $1.59 and the 200-day simple moving average is $1.70, with resistance pegged at $1.87.
The 30-day price range spans from $1.14 to $1.95, indicating a relatively tight trading band around the current price. These metrics suggest limited upside momentum in the immediate horizon as the price tests support and resistance levels.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.27 | $1.44 | $1.84 | 0% | Neutral | |
| $1.16 | $1.52 | $2.14 | +6% | Neutral | |
| $1.18 | $1.61 | $2.39 | +12% | Neutral | |
| $1.18 | $1.68 | $2.58 | +16% | Neutral | |
| $1.49 | $2.18 | $3.47 | +51% | Bullish | |
| $1.73 | $2.62 | $4.28 | +82% | Bullish | |
| $1.81 | $2.82 | $4.73 | +96% | Bullish | |
| $1.73 | $2.76 | $4.74 | +92% | Bullish | |
| $1.63 | $2.67 | $4.68 | +86% | Bullish | |
| $1.79 | $3.01 | $5.38 | +109% | Bullish | |
| $2.55 | $4.80 | $9.29 | +233% | Bullish | |
| $3.39 | $7.54 | $16.34 | +424% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.27 | $1.44 | $1.76 | +0.00% |
| August 2026 | $1.23 | $1.47 | $1.82 | +2.13% |
| September 2026 | $1.15 | $1.39 | $1.75 | -5.31% |
| October 2026 | $1.10 | $1.34 | $1.71 | -3.61% |
| November 2026 | $1.13 | $1.39 | $1.79 | +3.72% |
| December 2026 | $1.14 | $1.41 | $1.84 | +1.37% |
Click any year to see its month-by-month BYSI forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect BYSI to range from $1.27 to $1.84 through 2026. The $1.44 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The BYSI price prediction for 2027 points to an average of $1.52 (low $1.16, high $2.14) — a potential gain of +6% on today's $1.44. A consolidation phase looks the most probable path here.
In 2028, BYSI is projected to trade between $1.18 and $2.39, averaging $1.61 — a potential gain of +12% from today's $1.44. That is up +6% on the projected 2027 average. Price action looks broadly range-bound.
BeyondSpring Inc.'s 2029 outlook centres on $1.68, within a $1.18 to $2.58 range. That is up +4% on the projected 2028 average. That marks a +16% change versus current levels. A consolidation phase looks the most probable path here.
By 2030, BYSI could reach as high as $3.47, with a base case around $2.18 and support toward $1.49 — roughly +51% from $1.44. Momentum favours further upside here.
Expect BYSI to range from $1.73 to $4.28 through 2031. The $2.62 average target implies a +82% move from current prices. That is up +20% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The BYSI price prediction for 2032 points to an average of $2.82 (low $1.81, high $4.73) — a potential gain of +96% on today's $1.44. Momentum favours further upside here.
In 2033, BYSI is projected to trade between $1.73 and $4.74, averaging $2.76 — a potential gain of +92% from today's $1.44. That is -2% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
BeyondSpring Inc.'s 2034 outlook centres on $2.67, within a $1.63 to $4.68 range. That is -3% versus the projected 2033 average. That marks a +86% change versus current levels. Momentum favours further upside here.
By 2035, BYSI could reach as high as $5.38, with a base case around $3.01 and support toward $1.79 — roughly +109% from $1.44. Buyers look set to stay in control over this stretch.
Expect BYSI to range from $2.55 to $9.29 through 2040. The $4.80 average target implies a +233% move from current prices. That is up +60% on the projected 2035 average. Momentum favours further upside here.
The BYSI price prediction for 2050 points to an average of $7.54 (low $3.39, high $16.34) — a potential gain of +424% on today's $1.44. Buyers look set to stay in control over this stretch.
Investing $1,000 in BYSI today (≈ 694.444444 BYSI) could be worth
$5,236.24
+$4,236.24 (+424%) by 2050 · US Dollar
Based on the average projected BYSI price of $7.54 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BYSIwould be worth at today's price.
$1,000 invested in BYSI on Jul 10, 2025 (≈ 444.444444 BYSI) would be worth
$640
-$360 (-36.0%) today · 0.64× · US Dollar
Based on a BYSI entry price of $2.25 vs. today's $1.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.87 | $770.05 | -23.0% |
| 1 month ago | $1.65 | $872.73 | -12.7% |
| 3 months ago | $1.74 | $827.59 | -17.2% |
| 6 months ago | $1.66 | $867.47 | -13.3% |
| 1 year ago | $2.25 | $640 | -36.0% |
| All time (5.0y) ago | $10.55 | $136.49 | -86.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BYSI forecast.
Our base-case forecast reaches $2.90 around 2035.
Implied market cap at $2.90: $119.25M
The multi-year forecast shows a bullish trajectory starting in 2030, with the 2030 average price at $2.32 and a max of $3.71, and a 2030 ROI of 55.8%. The forecast continues to rise through 2035 (avg $3.22; max $5.79; ROI 116.2%) and into 2040 (avg $5.20; max $10.12; ROI 248.8%), culminating in 2050 with an average price of $8.23 and a max of $17.97, and a ROI of 452.3%. Sentiment is listed as neutral for 2026–2029 and bullish for 2030 and beyond, reflecting a shift to stronger upside expectations over the longer horizon.
These projections are estimates and not guarantees, and actual results may differ.
Tap a question to reveal the answer.
In 2030, the forecast shows an average price of $2.32 with a min of $1.57 and a max of $3.71, and a projected ROI of 55.8%.
The forecast indicates neutral sentiment for 2026–2029, then bullish from 2030 onward, with an average price of $2.32 in 2030 and a long-run average of $8.23 in 2050, and a 2050 ROI of 452.3%. These are estimates and not guarantees.
Yes. The 2030 forecast lists a max of $3.71 and the 2032 max of $5.06, while the 2030 avg is $2.32, suggesting it could exceed $3 in the 2030–2032 window.
The current price is $1.49 and the market capitalization is $61.27M.
The near-term technical setup is bearish with a 30-day range low of $1.14 and high of $1.95, current price at $1.49, RSI(14) at 40, SMA50 at $1.59, and SMA200 at $1.70, with near-term support at $1.49 and resistance at $1.87.
BeyondSpring Inc. Community Discussion
0Share your BeyondSpring Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.